Reinsurance Group of America (RGA) to Announce Quarterly Earnings on Thursday

Reinsurance Group of America (NYSE:RGA) is anticipated to issue its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Reinsurance Group of America to announce earnings of $6.50 per share and revenue of $6.6740 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 7, 2026 at 10:00 AM ET.

Reinsurance Group of America (NYSE:RGA) last issued its earnings results on Thursday, May 7th. The insurance provider reported $6.97 EPS for the quarter, topping the consensus estimate of $6.03 by $0.94. Reinsurance Group of America had a return on equity of 13.16% and a net margin of 4.92%.The business had revenue of $6.49 billion during the quarter, compared to the consensus estimate of $6.47 billion. During the same quarter last year, the company earned $5.66 EPS. The firm’s revenue was up 23.5% compared to the same quarter last year. On average, analysts expect Reinsurance Group of America to post $27 EPS for the current fiscal year and $29 EPS for the next fiscal year.

Reinsurance Group of America Trading Down 0.1%

Shares of Reinsurance Group of America stock opened at $236.71 on Tuesday. The company’s 50-day moving average price is $219.78 and its 200-day moving average price is $212.45. The company has a market cap of $15.51 billion, a price-to-earnings ratio of 12.82 and a beta of 0.47. Reinsurance Group of America has a 12-month low of $175.28 and a 12-month high of $245.00. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.46.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. JPMorgan Chase & Co. increased their target price on shares of Reinsurance Group of America from $270.00 to $286.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Barclays boosted their price target on shares of Reinsurance Group of America from $268.00 to $278.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Piper Sandler decreased their price target on shares of Reinsurance Group of America from $263.00 to $261.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. TD Cowen increased their price objective on Reinsurance Group of America from $212.00 to $235.00 and gave the stock a “hold” rating in a research report on Wednesday, July 22nd. Finally, UBS Group raised Reinsurance Group of America from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $255.00.

Insider Activity at Reinsurance Group of America

In other news, EVP Ronald Herrmann sold 7,000 shares of Reinsurance Group of America stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $210.58, for a total transaction of $1,474,060.00. Following the completion of the sale, the executive vice president directly owned 3,938 shares of the company’s stock, valued at approximately $829,264.04. The trade was a 64.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP John W. Hayden sold 414 shares of Reinsurance Group of America stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $214.95, for a total transaction of $88,989.30. Following the sale, the executive vice president directly owned 20,949 shares of the company’s stock, valued at $4,502,987.55. This represents a 1.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in RGA. Goldman Sachs Group Inc. boosted its stake in Reinsurance Group of America by 44.3% in the first quarter. Goldman Sachs Group Inc. now owns 221,198 shares of the insurance provider’s stock worth $43,554,000 after buying an additional 67,880 shares in the last quarter. Focus Partners Wealth lifted its holdings in shares of Reinsurance Group of America by 121.2% in the 1st quarter. Focus Partners Wealth now owns 2,676 shares of the insurance provider’s stock worth $527,000 after acquiring an additional 1,466 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Reinsurance Group of America by 17.6% in the 1st quarter. Geneos Wealth Management Inc. now owns 388 shares of the insurance provider’s stock valued at $76,000 after purchasing an additional 58 shares in the last quarter. Gabelli Funds LLC purchased a new stake in shares of Reinsurance Group of America in the 2nd quarter valued at $1,006,000. Finally, Cerity Partners LLC boosted its stake in shares of Reinsurance Group of America by 15.5% in the 2nd quarter. Cerity Partners LLC now owns 33,716 shares of the insurance provider’s stock valued at $6,688,000 after purchasing an additional 4,527 shares in the last quarter. Institutional investors own 95.11% of the company’s stock.

Reinsurance Group of America Company Profile

Reinsurance Group of America, Incorporated (NYSE: RGA) is a leading global provider of life and health reinsurance solutions. Headquartered in St. Louis, Missouri, RGA partners with primary insurance companies to help them manage risk, improve capital efficiency and develop innovative products. The company’s offerings span traditional risk transfer, financial solutions and facultative underwriting services, enabling clients to address a wide range of mortality, longevity, morbidity and critical-illness exposures.

RGA’s product suite includes life reinsurance, living benefits reinsurance, structured reinsurance and financial solutions that support product innovation and capital management.